Tirzepitide (Zepbound)
Classification
GIP/GLP-1 receptor agonist
Indication
Weight Loss, Type 2 DM
Benefits
Weight Loss, Decreases visceral fat, Improves insulin sensitivity
Mechanism of Action
Enhancing glucose-dependent insulin secretion, appetite suppression, delays gastric emptying
Pricing
Starting at $300/month